Block L H, Ruhenstroth-Bauer G
Blut. 1979 Feb 19;38(2):93-101. doi: 10.1007/BF01007950.
The first isolation and characterization of a lymphokine, the human MIF (MSF), and the availability of a specific MIF (MSF)-antibody provide an opportunity to establish a new parameter for detection of cellular immune mechanisms in various clinical situations. The precise estimation of quantitative amounts of MIF by sensitive immunochemical techniques could gain new insights into the pathogenesis of a number of clinical disorders. In addition, the exact detection of quantitative amounts of MIF in body fluids could have prognostic value.
人类巨噬细胞移动抑制因子(MIF,又称MSF)的首次分离与特性鉴定,以及特异性MIF(MSF)抗体的可得性,为在各种临床情况下建立检测细胞免疫机制的新参数提供了契机。通过灵敏的免疫化学技术精确估算MIF的定量,可能会为多种临床疾病的发病机制带来新的见解。此外,准确检测体液中MIF的定量可能具有预后价值。